CRISPR-Cas9 Editing of Myeloid Lectins Reveals Target-Dependent Transcriptional Remodeling in Tumor-Associated Macrophages
Gonçalo Trindade, Miguel Pinto, Giacomo Domenici, José Miguel Escandell, Catarina Brito
This study uses CRISPR-Cas9 to perturb myeloid lectins in macrophages, revealing target-specific transcriptional changes and immunometabolic reprogramming in tumor-associated macrophages.
bioRxiv · Oct 6, 2026 · PreprintCancer Biology